Independent Prognostic Value of Pulmonary Diffusing Capacity in Nonsmoking Patients with Chronic Heart Failure

International Heart Journal
Kenji NakamuraToshihisa Anzai

Abstract

The diffusing capacity of the lung for carbon monoxide (DLCO) is indicative of the alveolar-capillary membrane function. A reduced DLCO is associated with poor prognosis in chronic heart failure (HF). However, the significance of DLCO as an independent prognostic predictor has not been established. Here, we aimed to determine the prognostic value of DLCO in patients with chronic HF.We enrolled 214 patients (139 females, mean age: 63 ± 16 years, left ventricular ejection fraction [LVEF]: 45 ± 21%) with stable chronic HF who underwent pulmonary function tests. Only never smokers were included in the analysis because smoking can decrease DLCO.During a median follow-up period of 2.1 years, 52 patients (24.3%) experienced cardiac events, including unplanned HF admissions, left ventricular assist device (LVAD) implantations, all-cause deaths, and cardiopulmonary arrests (CPAs). The median percent predicted DLCO (%DLCO) was 87.3%. In a Cox regression analysis, a %DLCO of ≤87.3% was independently associated with the cardiac events, even after adjusting for age, sex, systolic blood pressure (SBP), LVEF, anemia, brain natriuretic peptide, estimated glomerular filtration rate (eGFR), and prior HF admission (hazard ratio [HR]: 1.87, 95% co...Continue Reading

References

Aug 1, 1996·European Heart Journal·D C LindsayP A Poole-Wilson
Mar 1, 1997·In Vitro Cellular & Developmental Biology. Animal·G S FilippatosB D Uhal
Sep 1, 2000·The European Respiratory Journal·L H SteenhuisT W van der Mark
Oct 31, 2000·American Heart Journal·P AgostoniG Marenzi
Apr 12, 2003·Critical Care Medicine·Carmine G De PasqualeAndrew D Bersten
Jun 7, 2003·American Journal of Respiratory and Critical Care Medicine·Panagiota I LatsiAthol U Wells
Sep 5, 2003·Basic Research in Cardiology·Martyn P KingsburyDesmond J Sheridan
Aug 11, 2004·Circulation·Carmine G De PasqualeAndrew D Bersten
Oct 10, 2006·European Heart Journal·Piergiuseppe AgostoniCesare Fiorentini
May 11, 2007·International Journal of Cardiology·Maurizio BussottiPiergiuseppe Agostoni
Jan 26, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Nobuyuki ShibaHiroaki Shimokawa
Feb 5, 2008·Heart Failure Reviews·Yi-Da Tang, Stuart D Katz
May 8, 2008·British Journal of Clinical Pharmacology·Desak Ketut ErnawatiJeffery David Hughes
Jul 29, 2010·Congestive Heart Failure·Steven M Dean, William Abraham
Nov 10, 2010·Nature Reviews. Cardiology·Anh L BuiGregg C Fonarow
Sep 1, 2012·The European Respiratory Journal·Robert NaeijeRebecca Vanderpool
Sep 24, 2013·Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine·Thomas P OlsonBruce D Johnson
May 13, 2017·International Heart Journal·Mengchao JinXinli Li
Jul 19, 2017·International Heart Journal·Kensuke NomaYukihito Higashi
Apr 24, 2018·International Heart Journal·Zhili XuZhang Wu

❮ Previous
Next ❯

Citations

May 5, 2021·Sleep & Breathing = Schlaf & Atmung·Dries TestelmansB Buyse
Jan 21, 2021·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Masaki TsujiIssei Komuro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.